PGC-1? functions as a co-suppressor of XBP1s to regulate glucose metabolism.

ABSTRACT: Peroxisome proliferator-activated receptor ? (PPAR?) coactivator-1? (PGC-1?) promotes hepatic gluconeogenesis by activating HNF4? and FoxO1. PGC-1? expression in the liver is highly elevated in obese and diabetic conditions, leading to increased hepatic glucose production. We previously showed that the spliced form of X-box binding protein 1 (XBP1s) suppresses FoxO1 activity and hepatic gluconeogenesis. The shared role of PGC-1? and XBP1s in regulating FoxO1 activity and gluconeogenesis led us to investigate the probable interaction between PGC-1? and XBP1s and its role in glucose metabolism.We investigated the biochemical interaction between PGC-1? and XBP1s and examined the role of their interaction in glucose homeostasis using animal models.We show that PGC-1? interacts with XBP1s, which plays an anti-gluconeogenic role in the liver by suppressing FoxO1 activity. The physical interaction between PGC-1? and XBP1s leads to suppression of XBP1s activity rather than its activation. Upregulating PGC-1? expression in the liver of lean mice lessens XBP1s protein levels, and reducing PGC-1? levels in obese and diabetic mouse liver restores XBP1s protein induction.Our findings reveal a novel function of PGC-1? as a suppressor of XBP1s function, suggesting that hepatic PGC-1? promotes gluconeogenesis through multiple pathways as a co-activator for HNF4? and FoxO1 and also as a suppressor for anti-gluconeogenic transcription factor XBP1s.

SUBMITTER: Lee J 

PROVIDER: S-EPMC5784318 | biostudies-other | 2018 Jan

REPOSITORIES: biostudies-other